Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer

Condition:   Esophageal Cancer
Interventions:   Drug: Durvalumab;   Drug: Tremelimumab;   Drug: Oxaliplatin;   Drug: Capecitabine;   Radiation: Radiotherapy
Sponsors:   Ludwig Institute for Cancer Research;   AstraZeneca
Not yet recruiting - verified March 2016

from #ORL via xlomafota13 on Inoreader http://ift.tt/1WpB3vM
via IFTTT